CHARGED ALPHATMFrontier AI stock research

MDLN · NasdaqGS

Medline Inc.

Medical Instruments & Supplies · United States

USD 31.64-1.5% daily changeQuote 2026-09-18 · USD
Market cap (USD)
US$42.57B
Trailing P/E
39.55x
Forward P/E
19.95x
Quarterly revenue growth
11.6%
Trailing net margin
2.3%
Indicated dividend yield

Snapshot 2026-09-21 · Latest financial period 2026-06-27 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-11-04 (provider estimate, not issuer-confirmed).

Company background

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Company website

Q2 2026

Go beyond the headline.

Medline (MDLN): They Beat By 52%. The Beat Was A Tariff Refund.

Published 2026-08-05

Comparable businesses

MDLN peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricMDLNMedline Inc.Snapshot 2026-09-21Financial period: 2026-06-27BDXBecton, Dickinson and CompanySnapshot 2026-09-20Financial period: 2026-06-30ALCAlcon Inc.Snapshot 2026-09-21Financial period: 2026-06-30Peer medianSimilar-size peers only
Market capMarket value, converted to USDUS$42.57BUS$49.29BUS$31.44BUS$40.36Bn=2
Forward P/EProvider forward earnings estimate19.95x13.61x16.35x14.98xn=2
EV / EBITDAEnterprise value / trailing EBITDA17.95x10.68x14.68x12.68xn=2
Revenue growthLatest quarter vs prior-year quarter11.6%5.4%8.7%7.0%n=2
Operating marginLatest reported quarter0.8%15.7%14.6%15.2%n=2
Free cash flow yieldTrailing cash flow / market cap2.0%9.1%4.0%6.6%n=2
Net debt / EBITDANet debt / trailing EBITDA3.95x2.63x1.60x2.11xn=2
Debt / equityTotal debt / positive book equity0.66x0.69x0.25x0.47xn=2
Trailing P/ETrailing twelve-month earnings39.55x31.36x49.65x40.50xn=2
Price / bookPrice / positive book equity per share2.40x2.02x1.46x1.74xn=2
EV / salesEnterprise value / trailing revenue1.51x2.91x3.25x3.08xn=2
Earnings growthLatest quarter vs prior-year quarter262.0%-31.4%
Gross marginTrailing twelve months25.1%46.9%57.2%52.1%n=2
Net marginTrailing twelve months2.3%4.2%5.9%5.1%n=2
Return on equityProvider trailing return; positive equity only4.9%6.6%2.9%4.8%n=2
Free cash flow marginTrailing free cash flow / revenue2.8%19.9%11.7%15.8%n=2
Dividend yieldIndicated annual dividend / price2.3%0.6%1.4%n=2
Earnings payoutProvider trailing dividend payout0.0%72.5%27.0%49.8%n=2
Current ratioCurrent assets / current liabilities4.33x0.86x2.09x1.48xn=2
BetaProvider historical market sensitivity0.280.700.49n=2

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-09-21. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for MDLN

All available reporting periods
Q2 20262026-08-05

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.